Thomas J. Arneson

1.7k total citations
20 papers, 1.2k citations indexed

About

Thomas J. Arneson is a scholar working on Nephrology, Epidemiology and Surgery. According to data from OpenAlex, Thomas J. Arneson has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Thomas J. Arneson's work include Dialysis and Renal Disease Management (9 papers), Erythropoietin and Anemia Treatment (3 papers) and Medication Adherence and Compliance (2 papers). Thomas J. Arneson is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Erythropoietin and Anemia Treatment (3 papers) and Medication Adherence and Compliance (2 papers). Thomas J. Arneson collaborates with scholars based in United States, France and United Kingdom. Thomas J. Arneson's co-authors include David T. Gilbertson, Allan J. Collins, Eric D. Weinhandl, Jiannong Liu, Robert N. Foley, Jon J. Snyder, David G. Lewallen, L. Joseph Melton, W. Michael O’Fallon and Shuling Li and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and PEDIATRICS.

In The Last Decade

Thomas J. Arneson

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Arneson United States 13 559 394 199 188 160 20 1.2k
Alfonso M. Cueto–Manzano Mexico 21 1.0k 1.9× 256 0.6× 113 0.6× 192 1.0× 158 1.0× 100 1.6k
Karl‐Göran Prütz Sweden 16 815 1.5× 244 0.6× 72 0.4× 116 0.6× 83 0.5× 24 1.1k
A. De Vecchi Italy 16 908 1.6× 272 0.7× 176 0.9× 300 1.6× 52 0.3× 41 1.4k
Stanley Fan United Kingdom 19 989 1.8× 328 0.8× 46 0.2× 221 1.2× 120 0.8× 38 1.2k
Ferruccio Conte Italy 21 1.2k 2.1× 426 1.1× 182 0.9× 247 1.3× 37 0.2× 64 1.9k
Dinanda J. de Jager Netherlands 11 573 1.0× 234 0.6× 95 0.5× 82 0.4× 35 0.2× 15 1.0k
Erik Roys United States 12 690 1.2× 378 1.0× 139 0.7× 294 1.6× 23 0.1× 16 1.4k
Anna Mathew United States 20 813 1.5× 471 1.2× 81 0.4× 249 1.3× 51 0.3× 52 1.5k
Yingbo Na Canada 19 664 1.2× 549 1.4× 73 0.4× 398 2.1× 113 0.7× 35 1.6k
Christian G. Rabbat Canada 16 433 0.8× 472 1.2× 189 0.9× 188 1.0× 34 0.2× 29 1.5k

Countries citing papers authored by Thomas J. Arneson

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Arneson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Arneson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Arneson more than expected).

Fields of papers citing papers by Thomas J. Arneson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Arneson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Arneson. The network helps show where Thomas J. Arneson may publish in the future.

Co-authorship network of co-authors of Thomas J. Arneson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Arneson. A scholar is included among the top collaborators of Thomas J. Arneson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Arneson. Thomas J. Arneson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Mi Rim, Craig A. Solid, Victoria M. Chia, et al.. (2014). Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy. Supportive Care in Cancer. 22(6). 1619–1628. 16 indexed citations
2.
Arneson, Thomas J., Shuling Li, Jiannong Liu, et al.. (2013). Trends in Hip Fracture Rates in US Hemodialysis Patients, 1993-2010. American Journal of Kidney Diseases. 62(4). 747–754. 64 indexed citations
3.
Weinhandl, Eric D., Thomas J. Arneson, & Wendy L. St. Peter. (2013). Clinical Outcomes Associated With Receipt of Integrated Pharmacy Services by Hemodialysis Patients: A Quality Improvement Report. American Journal of Kidney Diseases. 62(3). 557–567. 22 indexed citations
4.
Gilbertson, David T., Yi Peng, Thomas J. Arneson, Stephan Dunning, & Allan J. Collins. (2013). Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics. BMC Nephrology. 14(1). 44–44. 20 indexed citations
5.
Cetin, Karynsa, Shuling Li, Anne Blaes, et al.. (2013). Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States. Urology. 81(6). 1184–1189. 7 indexed citations
6.
Arneson, Thomas J., Shuling Li, Yi Peng, et al.. (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clinical Epidemiology. 4. 87–87. 187 indexed citations
7.
Cetin, Karynsa, Shuling Li, Anne Blaes, et al.. (2012). Prevalence of nonmetastatic (M0) prostate cancer (PC) patients on continuous androgen deprivation therapy (ADT) in the United States.. Journal of Clinical Oncology. 30(15_suppl). 4659–4659. 1 indexed citations
8.
Weinhandl, Eric D., Jiannong Liu, David T. Gilbertson, Thomas J. Arneson, & Allan J. Collins. (2012). Survival in Daily Home Hemodialysis and Matched Thrice-Weekly In-Center Hemodialysis Patients. Journal of the American Society of Nephrology. 23(5). 895–904. 147 indexed citations
9.
Arneson, Thomas J., Shuling Li, David T. Gilbertson, et al.. (2012). Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis‐stimulating agent and transfusion use in chemotherapy‐treated cancer patients. Pharmacoepidemiology and Drug Safety. 21(8). 857–864. 10 indexed citations
10.
Weinhandl, Eric D., Jiannong Liu, David T. Gilbertson, Thomas J. Arneson, & Alan Collins. (2011). 347 Relative Mortality in Daily Home and Matched, Thrice-Weekly In-Center Hemodialysis Patients. American Journal of Kidney Diseases. 57(4). B103–B103. 2 indexed citations
11.
Weinhandl, Eric D., Robert N. Foley, David T. Gilbertson, et al.. (2010). Propensity-Matched Mortality Comparison of Incident Hemodialysis and Peritoneal Dialysis Patients. Journal of the American Society of Nephrology. 21(3). 499–506. 251 indexed citations
12.
Mau, Lih-Wen, Jiannong Liu, Yang Qiu, et al.. (2010). Trends in Patient Characteristics and First-Year Medical Costs of Older Incident Hemodialysis Patients, 1995-2005. American Journal of Kidney Diseases. 55(3). 549–557. 17 indexed citations
13.
Foley, Robert N., Tricia Roberts, Jiannong Liu, et al.. (2010). Mortality from Cancer among US Hemodialysis Patients, 1995–2005. American Journal of Nephrology. 31(6). 518–526. 5 indexed citations
14.
Arneson, Thomas J., Jiannong Liu, Yang Qiu, et al.. (2010). Hospital Treatment for Fluid Overload in the Medicare Hemodialysis Population. Clinical Journal of the American Society of Nephrology. 5(6). 1054–1063. 64 indexed citations
15.
Ishani, Areef, Haifeng Guo, Thomas J. Arneson, et al.. (2009). Possible Effects of the New Medicare Reimbursement Policy on African Americans with ESRD. Journal of the American Society of Nephrology. 20(7). 1607–1613. 10 indexed citations
16.
Collins, Allan J., Joseph A. Vassalotti, Changchun Wang, et al.. (2009). Who Should Be Targeted for CKD Screening? Impact of Diabetes, Hypertension, and Cardiovascular Disease. American Journal of Kidney Diseases. 53(3). S71–S77. 63 indexed citations
17.
Peter, Wendy L. St., Shuling Li, Jiannong Liu, et al.. (2009). Effects of Monthly Dose and Regular Dosing of Intravenous Active Vitamin D Use on Mortality Among Patients Undergoing Hemodialysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(2). 154–164. 17 indexed citations
18.
Peterson, Kevin, David M. Radosevich, Patrick J. O’Connor, et al.. (2008). Improving Diabetes Care in Practice. Diabetes Care. 31(12). 2238–2243. 97 indexed citations
19.
Arneson, Thomas J., Russell V. Luepker, Phyllis L. Pirie, & Alan R. Sinaiko. (1992). Cholesterol Screening by Primary Care Pediatricians: A Study of Attitudes and Practices in the Minneapolis-St Paul Metropolitan Area. PEDIATRICS. 89(3). 502–505. 11 indexed citations
20.
Arneson, Thomas J., L. Joseph Melton, David G. Lewallen, & W. Michael O’Fallon. (1988). Epidemiology of Diaphyseal and Distal Femoral Fractures in Rochester, Minnesota, 1965-1984. Clinical Orthopaedics and Related Research. 234(234). 188–194. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfonso M. Cueto–Manzano Breakdown of academic impact, for papers by Karl‐Göran Prütz Breakdown of academic impact, for papers by A. De Vecchi Breakdown of academic impact, for papers by Stanley Fan Breakdown of academic impact, for papers by Ferruccio Conte Breakdown of academic impact, for papers by Dinanda J. de Jager Breakdown of academic impact, for papers by Erik Roys Breakdown of academic impact, for papers by Anna Mathew Breakdown of academic impact, for papers by Yingbo Na Breakdown of academic impact, for papers by Christian G. Rabbat
Rankless by CCL
2026